NCT02177292View on ClinicalTrials.gov

High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)

NAActive, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 23, 2010

Primary Completion Date

April 1, 2026

Study Completion Date

June 21, 2030

Conditions
Prostate Cancer
Interventions
RADIATION

Radiation Therapy

A high dose of radiation to the pelvic lymph nodes of 56 Gy (Gy/Gray = measure of amount of radiation) and at the same time give a boost (additional) radiation to the prostate itself (to 70 Gy).

Trial Locations (1)

53226

Froedtert & the Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT02177292 - High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB) | Biotech Hunter | Biotech Hunter